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Charting organellar importomes by quantitative
mass spectrometry
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Protein import into organelles is essential for all eukaryotes and facilitated by multi-protein
translocation machineries. Analysing whether a protein is transported into an organelle is
largely restricted to single constituents. This renders knowledge about imported proteins
incomplete, limiting our understanding of organellar biogenesis and function. Here we
introduce a method that enables charting an organelle’s importome. The approach relies on
inducible RNAi-mediated knockdown of an essential subunit of a translocase to impair import
and quantitative mass spectrometry. To highlight its potential, we established the
mitochondrial importome of Trypanosoma brucei, comprising 1,120 proteins including 331 new
candidates. Furthermore, the method allows for the identiﬁcation of proteins with dual or
multiple locations and the substrates of distinct protein import pathways. We demonstrate
the speciﬁcity and versatility of this ImportOmics method by targeting import factors in
mitochondria and glycosomes, which demonstrates its potential for globally studying protein
import and inventories of organelles.
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M
ost eukaryotic proteins are encoded in the nuclear
genome and synthesized in the cytosol, but many need
to be further sorted before they reach their ﬁnal
destination. These proteins follow distinct import pathways into
various organelles. The resulting protein inventories deﬁne the
identity and functions of organelles in eukaryotic cells. Knowing
the subcellular localization of a protein, its import route, and
the complete protein compendium of an organelle therefore lies
at the heart of cell biology.
A protein’s subcellular localization can be analysed micro-
scopically using ﬂuorescently labelled proteins or antibodies.
Alternatively, it can be determined biochemically by cell
fractionation. However, while the ﬁrst method allows the analysis
of proteins in living or at least morphologically intact cells, it
cannot easily be adopted to proteome-wide studies. Traditional
cell fractionation in combination with mass spectrometry (MS),
referred to as organellar proteomics1,2, does not suffer from
this drawback. However, it remains essentially impossible to
isolate organelles to homogeneity. This considerably limits the
accuracy of this approach, which is especially true for the
discrimination of low abundant organellar constituents and
co-purifying contaminants. Both approaches have also severe
limitations when dealing with proteins that are simultaneously
localized to more than one compartment. To alleviate some
of these restrictions, elaborate proteomic proﬁling approaches
employing quantitative MS have been implemented3–11.
In previous work, we used a global quantitative proﬁling
method to establish a most complete list of mitochondrial outer
membrane (OM) proteins of Trypanosoma brucei7. In the present
study, we sought to establish a map of the entire mitochondrial
proteome of T. brucei that is imported from the cytosol. With this
aim, we designed and implemented a method, which combines
the power of cell fractionation, stable isotope labelling (that is,
SILAC12, peptide stable isotope dimethyl labelling13) and
quantitative MS with an additional ﬁlter that speciﬁcally selects
for proteins whose mitochondrial localization depends on the
main protein translocation machinery located in the
mitochondrial OM. This ﬁlter is based on inducible knockdown
of the central, pore-forming subunit of the translocase to
efﬁciently impair mitochondrial protein import in vivo. We
demonstrate that this method overcomes issues of limited
speciﬁcity inherent to existing organellar proteomics approaches
as it provides information about whether a protein is imported or
not. It even allows for the unambiguous identiﬁcation of
mitochondrial proteins with dual or multiple localizations.
Moreover, the method holds the potential of globally
identifying the substrates of different protein import pathways
into mitochondria as demonstrated by targeting ATOM40,
SAM50 and ERV1. In a proof of concept study, we further
show its applicability to the mapping of proteins imported into
glycosomes. We believe that this versatile method will enable
scientists to address many of the still open questions related to
organellar proteomes.
Results
Loss of ATOM40 diminishes levels of substrate proteins. We
recently elucidated function and molecular architecture of the
archaic translocase of the mitochondrial outer membrane
(ATOM), which is essential for the import of mitochondrial
precursor proteins into the mitochondrion of the parasitic
protozoan T. brucei14,15. Here we exploit the fundamental role
of ATOM as main gatekeeper of mitochondria to develop
a method that permits to globally identify the pool of
mitochondria-imported proteins to which we refer to as the
‘mitochondrial importome’. To effectively impair import of
mitochondrial precursor proteins, we targeted ATOM40, which
is the central, pore-forming b-barrel protein of ATOM16 (Fig. 1a).
Following induction of RNA interference (RNAi)-mediated
knockdown of ATOM40, we observed two major effects when
analysing total cell lysates. First, unprocessed precursor forms of
some presequence-containing proteins accumulated (Fig. 1b,
CoxIV, mtHSP70, REAP1). As expected when protein import is
inhibited, these were localized in the cytosol (Fig. 1c). Second, the
steady-state levels of all mitochondrial proteins tested decreased
considerably (Fig. 1b), irrespective of their submitochondrial
localization and whether they contain a presequence or not.
In contrast, the levels of the cytosolic protein EF1a, which
serves as control for a non-imported protein, did not change.
We demonstrate that the observed reduction in the amounts of
mitochondrial proteins is not due to a change in their respective
messenger RNA levels (Fig. 1d). The simplest explanation
for these results is that ablation of ATOM40 causes a decrease
in the levels of imported proteins along with an accumulation
of non-imported, nuclear-encoded precursors in the cytosol.
However, the cytosolic accumulation is not always evident since
mistargeted proteins are rapidly degraded by the proteasome, as
evidenced by their slower degradation in the presence of the
proteasome inhibitor MG-132 (Fig. 1e). A similar effect has
recently been described for yeast17. Thus, the decrease of
the mitochondrial levels of imported proteins is mainly due to
reduced import. Yet, differences in the extent of reduction are
observed as not all imported proteins have the same half-lives in
mitochondria. The levels of imported proteins that are subunits
of protein complexes, for example, may even be further
reduced by intramitochondrial degradation if the levels of
putative binding partners become limiting. Nevertheless,
a reduction in the mitochondrial abundance of a protein in
induced ATOM40-RNAi cells is indicative of its mitochondrial
localization.
Deﬁning the mitochondrial importome. We envisioned that
the quantitative proteomic comparison of gradient-puriﬁed
mitochondria from induced (þTet) versus uninduced (Tet)
ATOM40-RNAi cells is an effective approach to delineate the
mitochondrial importome (Fig. 2a). With the exception of
OM proteins that do not rely on ATOM40 for membrane
insertion and mitochondrially encoded proteins, this importome
represents the entire mitochondrial proteome. The method,
which we termed ‘ImportOmics’, combines the advantages
of cell fractionation (that is, reduction of sample complexity
and enrichment of low abundant organellar proteins) with
a functional ﬁlter for speciﬁcally selecting proteins imported
into mitochondria. Most importantly, this ﬁlter is essentially
independent of the quality of the cell fractionation.
To test our approach, we ﬁrst established a small-scale
puriﬁcation protocol that allows for the isolation of mitochondria
by differential and Nycodenz density-gradient centrifugation18
from B1010 cells of the procyclic form of T. brucei (Suppleme-
ntary Fig. 1a). Second, we performed SILAC of ATOM40-RNAi
cells followed by RNAi induction (Fig. 2a and Supplementary
Fig. 1b). To minimize indirect effects of ATOM40 knockdown in
living cells, induced ATOM40-RNAi cells were harvested early, at
the onset of the growth arrest (3 days after induction)
(Supplementary Fig. 1b). Uninduced ATOM40-RNAi cells were
cultured in parallel and harvested at the same point in time. We
observed a comparable growth defect, a signiﬁcant reduction of
the RNAi target ATOM40, and an accumulation of COXIV
precursor in all four replicates (Supplementary Fig. 1b,c).
Gel-based liquid chromatography mass spectrometry (LC–MS)
analyses of mitochondria puriﬁed from SILAC-ATOM40
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knockdown and control cells (Fig. 2a) resulted in the
identiﬁcation of 2,564 proteins exhibiting at least one SILAC
ratio with an overlap of 2,133 proteins (83.2%) across all
replicates (Supplementary Fig. 2a, Supplementary Data 1). SILAC
ratios were highly reproducible between experiments with
Pearson correlation coefﬁcients in the range between 0.85 and
0.93 (Supplementary Fig. 2b). For further evaluation, we
considered 2,376 proteins (92%) to be reliably quantiﬁed
(for details, see ‘Methods’). Of these, 934 (39.3%) were part of
the mitochondrial reference proteome deﬁned in this work
(Supplementary Fig. 2c, Supplementary Data 2a). As depicted in
the volcano plot (Fig. 2b), most mitochondrial reference proteins
were decreased in abundance, demonstrating that their import
was distinctly impaired following ATOM40 ablation. These
data highlight the important role of ATOM40 for maintaining
the mitochondrial proteome by enabling import of nuclear-
encoded mitochondrial proteins.
We showed that loss of ATOM40 leads to the destabilization of
the whole ATOM complex15. In line with this, SILAC analysis of
mitochondria deﬁcient for ATOM40 (10.3-fold reduction)
revealed strongest effects on the two core subunits ATOM14
(9.7-fold red.) and ATOM11 (9.0-fold red.), the former protein
stabilizing the core complex and the latter promoting the
association of the core with its receptor subunits ATOM46 and
ATOM69 (ref. 15). Hence, downregulation of the receptors
ATOM46 (6.0-fold) and ATOM69 (4.6-fold) is presumably
a consequence of the loss of ATOM11. Interestingly, ATOM12
(2.4-fold red.), exhibiting an antagonistic function to ATOM11, is
least affected in addition to the recently identiﬁed new subunit
ATOM19 (ref. 14) (2.6-fold red.).
Another, more specialized translocase in the mitochondrial
OM of trypanosomes is the sorting and assembly machinery
(SAM) facilitating folding and insertion of b-barrel proteins into
the OM19,20. The pore-forming subunit of SAM is the highly
conserved SAM50, which itself is a b-barrel protein and requires
ATOM40 for import into mitochondria19. Accordingly, SAM50
levels were considerably reduced (3.4-fold) in mitochondria
lacking ATOM40 (Fig. 2b).
To exclude the possibility that inhibition of mitochondrial protein
import may indirectly cause the depletion of non-mitochondrial
a-TUB
KPAP1
a-TUB
MERS1
subunit subunit
a-TUB
KREN3
a-TUB
MRB
10130
a-TUB
MCP4
a-TUB
MRPS15
a-TUB
SDH
a-TUB
CYT C Ox
subunit subunit
a-TUB
Aconitase
a-TUB
mt
RNAP
+ – +
a-TUB
NDUFS1ATOM40
a-TUB
–Tet Tet
a
b
c
e
d
1 2 3 4 50+Tet (days)
ATOM40 knockdown
ATOM40
VDAC
mtHSP70
MCP5
COXIV
EF1a
p
m
m
p
m
CYT C
CYT C1
REAP1
O
M
IM
S
IM
M
at
rix p
ATOM40 knockdown
Tet
MG-132
–
+
–
–
+ +
ATOM40
VDAC
COXIV
MCP5
mtHSP70
REAP1
EF1a
P S
ATOM40 knockdown
T
Tet + + +–
p
m
p
m
COXIV
mtHSP70
EF1a
VDAC
–Tet +Tet
ATOM40
knockdown
OM
ATOM40
30
kDa
kDa
kDa
25
40
25
30
40
50
40
50
25
35
35
50
50
Figure 1 | Knockdown of ATOM40 reduces mitochondrial protein abundance. (a) Trypanosomal precursor proteins enter the mitochondrion through the
ATOM translocase located in the outer membrane (OM). Tetracycline (Tet)-induced RNAi-mediated knockdown (þTet) of the central protein import
pore ATOM40 impairs import of precursor proteins into the organelle resulting in the depletion of mitochondrial proteins. (b) Immunoblots showing the
steady-state levels of mitochondrial proteins in whole-cell extracts on Tet-induced RNAi of ATOM40. Proteins are: voltage-dependent anion channel
(VDAC), cytochrome c (CYT C), cytochrome c oxidase subunit 4 (COXIV), cytochrome c1 (CYT C1), mitochondrial carrier protein 5 (MCP5),
mitochondrial heat shock protein 70 (mtHSP70), and RNA-editing-associated protein 1 (REAP1). Precursors (p) and mature (m) protein forms are
indicated. Cytosolic elongation factor 1 alpha (EF1a) serves as a control. Submitochondrial locations of proteins are indicated. IM, inner membrane;
IMS, intermembrane space; OM, outer membrane. (c) Immunoblot analysis of whole cell (T) and digitonin-extracted, mitochondria-enriched pellet (P) and
soluble (S) fractions of uninduced (Tet) and induced (þTet) ATOM40-RNAi cells. Precursor (p) and mature (m) protein forms are indicated. EF1a
and VDAC serve as cytosolic and mitochondrial marker protein, respectively. (d) Northern blot analysis of mRNAs, isolated from uninduced (Tet)
and induced (þTet) ATOM40-RNAi cells, coding for known mitochondrial proteins, which were strongly downregulated on ablation of ATOM40
(see Supplementary Data 1). Alpha-tubulin (a-TUB) serves as loading control. (e) Immunoblot analysis of mitochondrial proteins in whole-cell extracts
from uninduced (Tet) and induced (þTet) ATOM40-RNAi cells cultured in the presence or absence of the proteasome inhibitor MG-132. Cytosolic EF1a
serves as control.
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proteins that would potentially be detected as false positive hits in an
ImportOmics experiment if co-puriﬁed with mitochondria, we
quantitatively analysed whole lysates of induced (þTet) versus
uninduced (Tet) ATOM40-RNAi cells to a depth of
5,144 proteins (Supplementary Data 3). In the SILAC–MS analysis
of these whole-cell extracts, we determined 523 proteins with
a minimum fold-change of 1.5 (P value o0.05, n¼ 3). Of these,
515 proteins were reduced in abundance of which the RNAi
target ATOM40 and its direct partner proteins ATOM14 and
ATOM11 were most affected, while only eight proteins were
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Figure 2 | Delineation of the ATOM40-dependent mitochondrial importome. (a) General workﬂow to study the mitochondrial importome. Using stable
isotope labelling by amino acid in cell culture (SILAC), procyclic ATOM40-RNAi cells were differentially labelled with heavy arginine (Arg10) and lysine
(Lys8) or their light counterparts (Arg0/Lys0). Tetracycline-induced (þTet) and uninduced (Tet) ATOM40-RNAi cells were mixed at day 3 after
induction and mitochondria were puriﬁed by differential and Nycodenz density gradient centrifugation (n¼4). Mitochondria were analysed using
a gel-based LC-MS approach followed by computational data analysis to establish the mitochondrial importome. (b) SILAC-RNAi data obtained in a were
visualized in a volcano plot. Proteins with a P value o0.05 (n¼4) and a mean log2 ratio of less than or equal to 0.62 were considered signiﬁcantly
decreased in abundance (shaded area) and represent the here established mitochondrial importome. Subunits of the ATOM complex and the b-barrel
protein SAM50 are annotated. Mitochondrial reference proteins (934) are depicted in black, others (1,442) in grey. (c–e) Volcano plot shown in b with
different classes of proteins highlighted in black as indicated. For details about mitochondrial inner membrane (IM) and outer membrane (OM) proteins as
well as the deﬁnition of non-mitochondrial reference proteins, see ‘Methods’ and Supplementary Data 1 and 2. (f) Distribution of 525 non-mitochondrial
reference proteins and 934 mitochondrial reference proteins quantiﬁed in gradient-puriﬁed mitochondrial fractions. For each reference set, the portion of
proteins that are part of the mitochondrial importome (mean log2 ratio less than or equal to 0.62, P valueo0.05, n¼4) is depicted in dark grey, while
the fraction of proteins that do not belong to the importome is depicted in light grey.
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upregulated. We further analysed the distribution of 918 mitochon-
drial and 1,160 non-mitochondrial reference proteins detected in
this experiment and found the steady-state levels of 411 mitochon-
drial but only three non-mitochondrial reference proteins to be
reduced in abundance by at least 1.5-fold (P value o0.05, n¼ 3;
Supplementary Fig. 3a). Thus, based on our proteome-wide SILAC
analysis of whole-cell extracts, we conclude that the depletion
of ATOM40 speciﬁcally diminished the mitochondrial proteome
but not the cellular proteome.
To demonstrate the speciﬁcity of our ImportOmics method, we
compared the effects of RNAi-mediated knockdown of ATOM40
and SAM50 by SILAC–MS analyses of organelle-enriched fractions
prepared from RNAi cells by single-step extraction using digitonin21.
In contrast to the extensive decrease of the mitochondrial proteome
following ATOM40 ablation (Supplementary Fig. 3b, Supplementary
Data 4), knockdown of SAM50 at an early time point only
resulted in a speciﬁc depletion of its b-barrel substrates VDAC, the
VDAC-like protein Tb927.11.10780 and ATOM40 together with its
closely associated partner ATOM14 (Supplementary Fig. 3c,
Supplementary Data 5). The data also show the scalability of the
method as it was combined with a fast and simple fractionation step
requiring only a low number (o108) of cells.
To eventually deﬁne a high-conﬁdence mitochondrial impor-
tome, we determined signiﬁcance thresholds for SILAC ratios of
our data set from gradient-puriﬁed mitochondria (Fig. 2b) using
the two sets of mitochondrial and non-mitochondrial reference
proteomes (Supplementary Fig. 4a,b, Supplementary Data 2a,b).
The validity of this approach is shown by the clear separation of
the two reference sets (Supplementary Fig. 4c). As a result, we
established here the mitochondrial importome comprising 1,120
proteins (Fig. 2b, shaded area). The remaining 1,256 proteins
largely represent co-purifying contaminants in gradient-puriﬁed
mitochondrial fractions.
We achieved high coverage of the mitochondrial inner
membrane (IM) (269/282 proteins, 95.4%) and OM constituents
(66/81, 81.5%)7 in our mitochondrial fractions (Fig. 2c,d,
Supplementary Data 1). Of note, the previously determined IM
and OM protein compositions were obtained from highly puriﬁed
mitochondrial subfractions7, whereas the source for this study
were isolated mitochondria. As expected, not all OM constituents
(25/66, 37.9%) are part of the importome (Fig. 2d). Biogenesis of
some trypanosomal integral OM proteins does not require
ATOM40, but depends on pATOM36 (ref. 22). Also in yeast,
several OM proteins with one or more transmembrane a-helical
segments are inserted independently of Tom40 (ref. 23). Some
require the mitochondrial import complex24, while others may
insert spontaneously or even use as yet unidentiﬁed insertases23.
Most importantly, though, the discriminative power of our
ImportOmics method is clearly demonstrated by the distribution
of non-mitochondrial reference proteins with 496 out of 525
(94.5%) not being affected following ATOM40 knockdown
(Fig. 2e,f, Supplementary Data 1) Thus, only 29 (5.5%) of the
non-mitochondrial reference proteins, but 789 (84.5%) of the
mitochondrial ones are part of the newly established importome
(Fig. 2f), underscoring the effectiveness of our method for the
global characterization of the imported mitochondrial proteome.
Identiﬁcation of 331 new mitochondrial candidate proteins.
We explored our importome data set for new mitochondrial
constituents and identiﬁed 331 proteins for which a mitochon-
drial localization has not been reported (Fig. 3a, Supplementary
Data 6). Justiﬁed by the virtual absence of obvious contaminants
(for example, cytoplasmic ribosomal, ﬂagellar and cytoskeletal
proteins) in our mitochondrial importome, we deemed these
proteins ‘new mitochondrial candidate proteins’. To validate our
data, we selected ﬁve candidates and further six proteins with
a reported, but so far unconﬁrmed mitochondrial localization,
tagged their C termini using the c-Myc epitope and expressed
them in procyclic T. brucei cells. Immunoﬂuorescence analysis
showed that all tagged proteins co-localized with ATOM40
(Fig. 3b, Supplementary Fig. 5), thus corroborating our
importome data.
In yeast, B60–70% of all mitochondrial precursor proteins
possess an N-terminal targeting signal23. We therefore searched
for the presence of putative N-terminal presequence segments in
the 331 new mitochondrial candidates using the algorithms
TargetP and MitoFates. N-terminal presequences were predicted
for 152 new candidates (46%) (Fig. 3c, Supplementary Data 6). In
comparison, 845 proteins (68.3%) of our mitochondrial reference
set contain putative targeting sequences (Supplementary Data 2a),
which is in accordance with yeast data23. We here propose that
many of the newly identiﬁed mitochondrial candidate proteins
may likely possess internal or so far uncharacterized targeting
signals. In fact, only 4 of the 11 newly validated mitochondrial
proteins contain a predicted N-terminal presequence
(Supplementary Data 6).
To obtain insight into potential functions, we classiﬁed new
mitochondrial candidates based on Gene Ontology (GO) slim
terms in the domains ‘biological process’, ‘cellular component’
and ‘molecular function’ (Fig. 3d, Supplementary Data 6).
However, only little information is available as most proteins
have so far not been characterized. For candidates with
annotations, the most frequent terms found were ‘amino-acid
metabolism’, ‘other metabolic processes’ and ‘oxidoreductase
activity’. Furthermore, we performed large-scale protein BLAST
analysis to identify functional orthologues in yeast, mouse or
human (Supplementary Data 7). We retrieved BLAST hits for
91 new mitochondrial candidates and of these, 46 had
orthologues in all three species (Fig. 3e), indicating that they
are evolutionary conserved. In fact, all 46 orthologues were
recently localized to human mitochondria9 and 42 to
mitochondria of mouse embryonic stem cells10.
To conclude, ImportOmics enabled the discovery of 331 new
mitochondrial candidate proteins, thereby expanding the known
mitochondrial proteome of T. brucei by more than 25%. We
believe that this rich dataset will trigger many follow-up studies
leading to a better understanding of mitochondrial biology.
Aminoacyl-tRNA synthetases localize to mitochondria. We
reasoned that the ImportOmics method should allow for the
identiﬁcation and localization of mitochondrial proteins that
do not exclusively reside in mitochondria but exhibit dual or
multiple subcellular locations. In T. brucei, the mitochondrial
genome is devoid of tRNA genes. This lack is compensated for
by import of a small fraction of essentially all cytosolic tRNAs25.
Thus, with very few exceptions, the same set of tRNAs is present
in both the cytosol and the mitochondrion. To function in
translation, each tRNA needs to be charged with the correct
amino acid by its corresponding aminoacyl-tRNA synthetase
(aaRS). T. brucei has 23 distinct aaRSs, 17 of which are encoded
by single-copy genes, while three are encoded by two genes
(LysRS-1/-2, AspRS-1/-2 and TrpRS-1/-2), corresponding to the
cytosolic or mitochondrial version of the enzyme. Thus, we would
assume that all of the 17 aaRS encoded by single-copy genes are
dually localized.
We attempted to demonstrate the postulated dual localization
for the trypanosomal tyrosyl-tRNA synthetase (TyrRS) using two
different biochemical fractionation methods. Figure 4a illustrates
that in a digitonin extraction of whole cells, the C-terminally
c-Myc-tagged TyrRS cofractionates with the cytosolic marker
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EF1a. The same observation is made when gradient-puriﬁed
mitochondria are analysed (Fig. 4b). From these results, we would
conclude that TyrRS is exclusively cytosolically localized.
ImportOmics, however, leads to a different conclusion. Using
this approach, we could demonstrate the mitochondrial localiza-
tion of 15 aaRSs. These comprise the mitochondria-speciﬁc
enzymes LysRS-2, AspRS-2 and TrpRS-2, while the others are
predicted to be dually localized. (Fig. 4c, Supplementary Data 1).
The fact that these aaRSs are speciﬁcally downregulated in
gradient-puriﬁed mitochondrial fractions on knockdown of
ATOM40 excludes them to be cytosolic contaminants. In line
with this, LysRS-1, which is known to be a cytosol-speciﬁc
enzyme25, while still detected in small amount in isolated
mitochondria, was not affected following ATOM40 depletion
(Fig. 4c, Supplementary Data 1). Thus, ImportOmics allows for
the reliable assignment of mitochondrial proteins with dual or
c
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multiple localizations of which only minute amounts are present
in mitochondria.
Identiﬁcation of putative substrates of the MIA pathway. Our
ImportOmics method provides the great potential for globally
identifying substrates of different import factors as indicated by
our SILAC data from ATOM40-RNAi and SAM50-RNAi
experiments (see Fig. 2b and Supplementary Fig. 3). To further
explore this intriguing possibility, we decided to target the
mitochondrial disulﬁde relay system involved in the import of the
majority of soluble intermembrane space (IMS) proteins. In yeast
and human, this pathway, which also mediates the oxidative
folding of its substrates, is termed mitochondrial intermembrane
space assembly (MIA) pathway and requires the oxidoreductase
MIA40 and the sulfhydryl oxidase ERV1/ALR26. Most of the so
far characterized MIA pathway substrates in yeast and human are
small and rich in cysteines that are arranged in either twin-Cx3C
or -Cx9C motives (with x being any amino acid except cysteine).
The double cysteine motifs stabilize their typical helix–loop–helix
core structure by formation of disulﬁde bonds. Typical
representatives of these classical MIA substrates are the tiny
TIM proteins, for example, TIM9 and TIM10 (ref. 27). Additional
substrates of this pathway such as Tim22 (refs 26,28) are more
complex and thus less easily identiﬁed.
In T. brucei, the MIA pathway is unusual as this organism
expresses an orthologue of ERV1 but lacks a MIA40 (refs 29,30).
Whether ERV1 alone is sufﬁcient to mediate import of small IMS
proteins or whether another unknown protein replaces MIA40
function is presently unknown. In addition, experimental
evidence for trypanosomal MIA pathway substrates is lacking.
Thus, to obtain novel insight, we chose ERV1 as RNAi target in
procyclic T. brucei cells (Fig. 5a). Induction of RNAi-mediated
knockdown of ERV1 resulted in a gradual decrease of the
steady-state levels of TIM9 (ref. 31; Fig. 5b), the human and
yeast orthologues of which are bona ﬁde MIA pathway
substrates32. In contrast, the steady-state levels of the soluble
IMS protein cytochrome c (CYT C) and the cytosolic protein
EF1a remained unchanged. In yeast, import of cytochrome
C into mitochondria was proposed to occur independently of
Erv1/Mia40 (ref. 28), which is in line with our data.
To globally identify MIA pathway substrates, we performed
ImportOmics. In our experiments, induced ERV1-RNAi cells
were harvested before onset of the growth phenotype (2.5 days
after induction; Supplementary Fig. 6a). We quantiﬁed proteins
in mitochondria-enriched fractions of induced (þTet) versus
uninduced (Tet) ERV1-RNAi cells by MS using peptide
stable isotope dimethyl labelling13. The analysis resulted in
the quantiﬁcation of 2,820 proteins, 2,520 (90%) of which were
quantiﬁed in each biological replicate with reproducible ratios
between the experiments (Supplementary Fig. 6b,c, Suppleme-
ntary Data 8). As depicted in Fig. 5c, 25 proteins were
signiﬁcantly reduced in abundance by at least twofold (P value
o0.05, n¼ 3) and, thus, were classiﬁed as putative MIA pathway
substrates. Among these were ﬁve tiny TIM proteins that we
previously detected in our recent study of the trypanosomal IM
protein import machinery33. We compiled a list of MIA
substrate-like proteins (Supplementary Data 9a) and predicted
classical MIA pathway substrates in T. brucei through a global
search for proteins with two or more Cx3C or Cx9C motifs that
are characteristic for mitochondrial IMS proteins (Supplementary
Data 9b). Such predicted MIA pathway substrates were clearly
overrepresented in the candidate list derived from our
ERV1-ImportOmics study in comparison to all quantiﬁed
proteins in the same experiment (Fig. 5d). Thus, we have
globally identiﬁed the substrates of the MIA pathway. The results
obtained in this analysis demonstrate the validity and the
effectiveness of ImportOmics for the identiﬁcation of in vivo
substrates of distinct protein import pathways of organelles.
Identiﬁcation of proteins imported into glycosomes. So far, we
successfully applied our ImportOmics method to mitochondria
and showed that it identiﬁes mitochondrial proteins regardless of
whether they exclusively localize to mitochondria or not.
Moreover, the method holds great potential for globally studying
substrates of different import factors as demonstrated by
targeting ATOM40, SAM50 and ERV1 of the same organelle. To
show that the method can also be applied to organelles other than
mitochondria, we selected the glycosome.
The glycosome is a specialized peroxisome-like organelle of
trypanosomatids, which harbours several enzymes of glycolysis34
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Figure 4 | Identiﬁcation of the mitochondrial pool of dually localized aminoacyl-tRNA synthetases. (a) Immunoblot analysis of whole-cell extract (T)
and digitonin-extracted, mitochondria-enriched pellet (P) and soluble (S) fractions of cells expressing C-terminally c-Myc-tagged tyrosyl-tRNA synthetase.
Dihydrolipoyl dehydrogenase (LipDH) and EF1a serve as mitochondrial and cytosolic marker, respectively. (b) Immunoblot analysis of fractions containing
equal amounts of proteins collected during isolation of mitochondria from the cell line analysed in Fig. 1a. T, whole-cell extract; C, cytosol; P, pellet after cell
lysis; crude mitos, crude mitochondria before gradient; mitos, gradient-puriﬁed mitochondria. LipDH and ATOM40 serve as mitochondrial markers and EF1a
as cytosolic marker. (c) Distribution of aminoacyl-tRNA synthetases quantiﬁed in the SILAC-based analysis of mitochondria isolated from induced (þTet)
and uninduced (Tet) ATOM40-RNAi cells. Same plot as in Fig. 2c with aminoacyl-tRNA synthetases marked in black.
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and components of other metabolic pathways including the
b-oxidation of fatty acids and the pentose–phosphate pathway34.
As known for peroxisomes, proteins destined for the matrix are
targeted to the glycosome either by a C-terminal peroxisomal
targeting sequence (PTS) 1 or an N-terminal PTS2 followed by
transport across the membrane mediated by multi-protein
complexes34. Work in yeast has shown that PTS1- and
PTS2-containing proteins are imported into peroxisomes using
two distinct import pores, which share the peroxin PEX14
(ref. 35). Furthermore, RNAi experiments indicate that the
PEX14 orthologue of trypanosomes is essential for growth
and survival of procyclic- and bloodstream-form parasites in
ba
0
8
1 2 3 4 5 6+Tet (days)
CYT C
TIM9
50EF1a
kDa
c
OM
IM
–Tet +Tet
ERV1
knockdown
ATOM ATOM
ERV1
ERV1
SH
SH
SH
SH
SH
SH
SH
SH
SH
SH
SH
SH
SS
SS
TIM8-13
Tb927.3.2650
Tb927.5.2560
Tb927.9.7980
Tb927.4.4990
Tb927.4.3430
Tb927.9.8260
TIM10
TIM9
Tb927.9.6620
Tb927.6.3530
TbTIM11
Tb927.10.12930
Tb927.10.11900
Tb927.2.2940
Tb927.10.15420
Tb927.10.4280
ATOM19
Tb927.10.15790
Tb927.11.13510
Tb927.8.4150
Tb927.9.11660
Tb927.8.8330
TbTIM13
COXVIII
–2 –1.5–3–4–5
Fold change (ERV1 RNAi +/– Tet) norm.
0
0
2
4
6
8
10
12
–1–2–3
–
lo
g 2
 
(P
va
lu
e) 
Mean log2 (ERV1 RNAi +/– Tet) norm.
Σ
d Significantly downregulated Other proteins
0 0.5 1 1.5 2
Cx3C/Cx9C motif
MIA substrate-like
Combined
Percent
2
29
29Cx3C/Cx9C motif
MIA substrate-like
Combined
0 20 40 60 80 100
Percent
14
11
13
*
*
*
*
*
*
*
*
*
*
*
*
*
*
25 proteins
Σ(    25 proteins) Σ(    2,718 proteins)
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glucose-containing medium36. Hence, we used an inducible
PEX14-RNAi cell line of procyclic T. brucei to impair glycosomal
matrix protein import (Fig. 6a). In this cell line, PEX14 is
efﬁciently depleted causing a growth arrest when cells are grown
on glucose (Supplementary Fig. 7a). Total cell extract, cytosolic
and crude glycosome-containing pellet fractions obtained
by differential centrifugation of uninduced and induced
PEX14-RNAi cells were analysed by immunoblotting (Fig. 6b).
The results show that following PEX14 depletion the levels of
glycosomal matrix proteins (ALD, GAPDH, G3PDH) were
reduced in the pellet fraction, but increased in the cytosol. We
therefore concluded that non-imported glycosomal proteins
remain stable in the cytosol, most likely because they are folded
before import. In contrast, GIM5, an abundant, dimeric
glycosomal integral membrane protein37, was not affected in its
localization and abundance following PEX14 knockdown
(Fig. 6b). This ﬁnding conﬁrms that glycosomal membrane
proteins do not depend on PEX14 for import34.
To show the applicability of our ImportOmics method to
glycosomes, we conducted a proof-of-concept study in which we
analysed the effects of PEX14 knockdown by SILAC–MS. As for
the immunoblot analysis in Fig. 6b, we did not purify glycosomes,
but used instead the glycosome-containing pellet fractions from
induced and uninduced PEX14-RNAi cells. LC–MS analyses
resulted in 2,032 protein identiﬁcations (with at least one SILAC
ratio) with an overlap of 1,726 proteins (84.9%, n¼ 3;
Supplementary Fig. 7b, Supplementary Data 10). SILAC ratios
were consistent between experiments (Supplementary Fig. 7c).
The volcano plot shown in Fig. 6c depicts the distribution of
SILAC ratios of 1,961 proteins identiﬁed in these fractions
(Supplementary Data 10). Based on the distribution of glycosomal
and non-glycosomal reference proteins (Supplementary Data 11),
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Figure 6 | Targeting PEX14 to reveal proteins imported into glycosomes. (a) PTS1- and PTS2-dependent import of nuclear-encoded glycosomal matrix
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the different samples. EF1a and VDAC serve as cytosolic and mitochondrial marker protein, respectively. (c) Volcano plot of SILAC-PEX14-RNAi data.
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‘molecular function’ (MF) and ‘biological process’ (BP). The number of proteins assigned to a given term is indicated.
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61 proteins were found to be distinctly decreased in abundance
(mean log2 ratio less than or equal to  0.59, P value o0.05,
n¼ 3). Our SILAC data corroborate immunoblotting results
(Fig. 6b, pellet fraction). Levels of glycosomal enzymes involved
in glycolysis were signiﬁcantly decreased following PEX14
ablation, while glycosomal membrane proteins or non-glycoso-
mal proteins were not affected (Fig. 6c, Supplementary Data 10).
The majority of the downregulated proteins (35 proteins, 57.4%)
are annotated as glycosomal proteins and 12 of these comprise
a putative PTS1 according to PSORT II (Fig. 6c, Supplementary
Data 10). Consistently, GO term enrichment analysis revealed
a strong overrepresentation of the terms ‘peroxisome’ and
‘carbohydrate metabolism’ as expected for glycosomes (Fig. 6d,
Supplementary Data 12).
Using a crude organellar fraction in which glycosomes were
present in very low amount (that is, estimated abundance of
o10% based on MS intensities), we were able to cover 60% of the
known glycosomal proteome38. We expect that the use of
fractions speciﬁcally enriched for glycosomes allows for a more
in-depth analysis of the PEX14-dependent glycosomal importome
and may shed light on the question whether alternative
import pathways exist. It is also important to mention that
the population of glycosomes (or peroxisomes) is rather
heterogeneous with only a part of this population being import
competent39. In addition, glycosomes are highly dynamic
organelles which likely import different sets of enzymes
depending on their metabolic state and the environmental
condition39. Our ImportOmics method may provide here an
effective approach to reveal potential differences in the import
capacity and matrix protein composition of glycosomes at
different physiological conditions.
Discussion
The ImportOmics method opens new avenues for globally studying
protein import into organelles through the combination of RNAi,
subcellular fractionation and quantitative MS. The method can be
adapted to different cellular protein import systems by targeting
a distinct, central component of their protein import machinery.
It is a versatile method that can be used in any other organism in
which inducible knockdown of a distinct component of an
organellar protein import machinery is feasible. We see advantages
over other approaches as the method provides speciﬁc information
about which proteins are imported into the organelle including
the detection of proteins that are only partially localized in this
membrane-surrounded cellular compartment. The method is
highly speciﬁc and applicable to organelles that cannot be puriﬁed
to homogeneity, although we see that the depth of the established
importome increases with the purity of the organelle. We envision
that the method offers many opportunities for studying organelles
that represent endpoints of protein trafﬁcking routes including
mitochondria-related organelles (for example, hydrogenosomes,
mitosomes), peroxisomes, chloroplasts and other plastids or the
nucleus. Many of these organelles are difﬁcult to purify and
ImportOmics may therefore be especially suited. Most importantly,
it holds great potential for globally identifying in vivo substrates
of various protein import pathways, for example, through ablation
of individual import receptor proteins or distinct components of
different protein import machines within the same organelle.
In addition to mitochondria and glycosomes as highlighted in
this work, ImportOmics should be in particular useful for the study
of chloroplasts and other plastids. In plastids, ImportOmics may
allow for assigning substrates to the different thylakoid protein
import systems. In plant and algae systems, we can envision
comparative ImportOmics experiments targeting mitochondria
and plastids.
We hope that the method will be widely used in cell biology
research to further advance our knowledge of how cell organelles
master the challenge to maintain and depend on a proteome that
is synthesized in the surrounding cytosol.
Methods
Transgenic cell lines. Transgenic cell lines are based on the procyclic T. brucei
strain 29-13 (ref. 40) and were grown at 27 C in SDM-79 (ref. 41) supplemented
with 10% (v/v) fetal calf serum. For SILAC experiments, cells were grown in
modiﬁed SDM-80 (ref. 42) containing 5.55mM glucose, 15% (v/v) dialysed fetal
calf serum (BioConcept, Switzerland), and either the unlabelled ‘light’ or stable
isotope-labelled ‘heavy’ versions of arginine (1.1mM; Arg0 or Arg10) and lysine
(0.4mM; Lys0 or Lys8) (Cambridge Isotope Laboratories, USA). Induction of
RNAi with tetracycline for 3 days (ATOM40 and SAM50) or 4 days (PEX14) was
started 2–3 days after beginning SILAC labelling of the cells.
Inducible RNAi-mediated knockdowns of ATOM40 (Tb927.9.9660),
PEX14 (Tb927.10.240) and ERV1 (Tb927.9.6060) were performed using
pLEW100-derived stemloop vectors, in which the phleomycine resistance gene had
been replaced with a blasticidine or, in the case of ERV1, a puromycine resistance
gene, and which allow for ligation of inserts in opposing directions separated
by a 460 bp spacer fragment using BamHI/XhoI and HindIII/XbaI restriction
sites16,40,43. The SAM50 (Tb927.3.4380) RNAi cell line has been described before44.
For inducible triple c-Myc-tagging of tyrosyl-tRNA synthetase (Tb927.7.3620) and
candidate proteins (Tb11.v5.0963, Tb927.6.1700, Tb927.11.3940, Tb927.10.8010,
Tb927.3.3680, Tb927.9.10630, Tb927.6.2070, Tb11.v5.0771, Tb927.8.580,
Tb927.9.11560 and Tb927.10.1580), the full-length open reading frames were
cloned into modiﬁed pLEW100 (ref. 40) expression vectors, in which the
phleomycine resistance gene had been replaced with a puromycine resistance gene
and a triple c-Myc cassette had been inserted for C-terminal positioning of the tag
using BamHI, HindIII or AgeI restriction sites15. A list of oligonucleotide primers
is provided in Supplementary Data 13.
Isolation of mitochondria. Mitochondria of high purity were isolated from
differentially SILAC-labelled tetracycline-treated and untreated ATOM40-RNAi
cells mixed in a 1:1 ratio based on cell counts. The isolation was performed under
isotonic conditions essentially as described before21 with the protocol being
adapted to lower cell numbers. Brieﬂy, a total ofB1.5 1010 cells were collected by
centrifugation (1,400 r.c.f., 4 C, 10min), washed in SBG buffer (22mM glucose,
150mM NaCl, 20mM sodium phosphate buffer pH 7.9), and resuspended in SoTE
buffer (20mM Tris–HCl pH 8.0, 2mM EDTA pH 8.0, 600mM sorbitol). Cells were
lysed by N2 cavitation (55 bar, 30min). After centrifugation (23,400 r.c.f. max, 4 C,
10min), the resulting pellet was resuspended in SoTE buffer and treated with
DNase (30min on ice). To remove intact cells and large debris, the lysate was
centrifuged (500 r.c.f., 4 C, 10min) and the pellet was discarded. Following
a further centrifugation step (23,400 r.c.f. max, 4 C, 10min), the pelleted material
was mixed with 50% Nycodenz and loaded at the bottom of a Nycodenz step
gradient (28% 3ml, 25% 2.5ml, 21% 2.5ml, 18% 2.5ml). After ultracentrifugation
(125,000 r.c.f. max., 4 C, 45min), mitochondrial vesicles were isolated from the
gradient and washed in SoTE buffer prior to mass spectrometric analysis. The
experiment was performed in four independent replicates including a label-switch.
Gradient-puriﬁed mitochondria were also prepared from cells grown under
standard conditions and expressing C-terminally triple c-Myc-tagged tyrosyl-tRNA
synthetase21. For immunoblot analysis, samples were taken at various steps during
the isolation procedure.
Digitonin fractionation. Cells were collected by centrifugation (1,400 r.c.f., 4 C,
10min) and washed with PBS. Plasma membranes were lysed by incubating the
cells in SoTE buffer containing 0.015% (w/v) digitonin (5min on ice). Subsequent
differential centrifugation (6,800 r.c.f., 4 C, 5min) yielded an organelle-enriched
pellet fraction and a fraction enriched for cytosolic proteins43. In case of SILAC
experiments, differentially labelled tetracycline-treated and untreated RNAi cells
were mixed in equal amounts prior to digitonin treatment. Organelle-enriched
fractions of SILAC-labelled ATOM40-, SAM50- or PEX14-RNAi cells were
each prepared in three independent replicates including a label-switch.
Organelle-enriched fractions of unlabelled ERV1-RNAi cells (þ /Tet) were
generated 2.5 days post induction with tetracycline.
SDS–PAGE and tryptic in-gel digestion. Gradient-puriﬁed mitochondria isolated
from SILAC-labelled ATOM40-RNAi cells (n¼ 4) as well as organelle-enriched
fractions generated from SILAC-labelled ATOM40- or PEX14-RNAi cells (n¼ 3)
were subjected to SDS–polyacrylamide gel electrophoresis (PAGE) prior to LC–MS
analysis. To this end, proteins of gradient-puriﬁed mitochondria from ATOM40-
RNAi cells were acetone-precipitated and resuspended in 1% (w/v) SDS/0.1 N
NaOH; organelle-enriched fractions from ATOM40- and PEX14-RNAi cells
were resuspended in urea buffer (8M urea/50mM NH4HCO3). Proteins
(30 mg per sample) were separated on 4–12% NuPAGE BisTris gradient gels
(Life Technologies) according to the manufacturer’s instructions. Proteins were
visualized using colloidal Coomassie Brilliant Blue and gel lanes cut into 12 slices.
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Following reduction of cysteine residues with 5mM Tris(2-carboxy-ethyl)pho-
sphine dissolved in 10mM NH4HCO3 (incubation for 30min at 37 C) and
subsequent alkylation of free thiol groups with 50mM iodoacetamide per 10mM
NH4HCO3 (30min at room temperature in the dark), proteins were in-gel digested
using trypsin (37 C, overnight).
Proteolytic in-solution digestion. SILAC-labelled intact cells of ATOM40-RNAi
experiments (referred to as ‘whole cells’) mixed in a 1:1 ratio (þ /Tet) as
well as organelle-enriched fractions from SAM50- and ERV1-RNAi cells were
resuspended in urea buffer. Proteins were reduced and alkylated as described
above. The alkylation reaction was quenched by adding dithiothreitol at a ﬁnal
concentration of 20–33mM. For tryptic digestion, urea concentration was adjusted
to 1.6–2M with 50mM NH4HCO3 and proteins were digested overnight at 37 C.
Proteins of ATOM40-RNAi whole cells were pre-digested with LysC in 6M urea
(37 C, 4 h) followed by tryptic digestion as described.
Stable isotope dimethyl labelling. Peptides of organelle-enriched fractions from
tetracycline-induced and uninduced ERV1-RNAi cells were differentially labelled
using ‘light’ formaldehyde (CH2O; Sigma-Aldrich) and sodium cyanoborohydride
(NaBH3CN; Sigma-Aldrich) or the ‘heavy’, deuterated versions thereof
(CD2O/NaBD3CN; Sigma-Aldrich). Prior to labelling, peptides were desalted using
StageTips and vacuum-dried. For labelling, peptides corresponding to 5 mg
(replicate 1) or 10mg of protein (replicates 2 and 3) were resuspended in 100 ml of
100mM tetraethylammonium bicarbonate, 4 ml of 4% (v/v) CH2O/CD2O, and 4 ml
of 0.6M NaBH3CN/NaBD3CN and incubated for 1 h at 20 C and 800 r.p.m.
Labelling reactions were stopped by adding 16 ml of 1% NH3. Samples were
subsequently acidiﬁed with 8 ml of 100% formic acid (FA). Differentially
dimethyl-labelled peptides of tetracycline-treated and untreated cells were mixed,
puriﬁed using StageTips, and dried in vacuo. The experiment was performed in
three independent replicates including a label-switch.
High pH reversed-phase fractionation. Peptides of ATOM40-RNAi whole cells
obtained from 300mg of protein per replicate (n¼ 3) were fractionated by high-pH
reversed-phase liquid chromatography45. To this end, peptides were desalted using
C18 cartridges (3M Empore, St Paul, USA) and dried in vacuo. Peptides were
resuspended in 99% solvent A (10mM ammonium hydroxide, pH 10) and
1% solvent B (10mM ammonium hydroxide in 90% ACN, pH 10) and loaded onto
a C18 Gemini-NX column (150mm 2mm inner diameter, particle size 3 mm,
pore size 110Å; Phenomenex, Torrence, USA) using an Ultimate 3000 HPLC
system (Thermo Fisher Scientiﬁc, Dreieich, Germany) with a ﬂow rate of
200ml min 1 and a column temperature of 40 C. Peptides were eluted with
a gradient of 1–61% solvent B (starting after 5min) in 60min followed by
61–78% B in 2min and 3min at 78%. One-minute fractions were collected
(starting after 1.5min, ending at 70.15min) in a concatenated manner such that
every 17th fraction was combined resulting in a total of 16 fractions.
Dimethyl-labelled peptides of ERV1-RNAi experiments were fractionated by
high-pH reversed-phase using StageTips. Peptides were resuspended in 10mM
NH4OH, loaded onto StageTips equilibrated with 10mM NH4OH, and eluted step-
wise with 10, 13, 15.6, 18.7, 40.5 and 72% ACN diluted in 10mM NH4OH resulting
in seven fractions including the ﬂow-through.
LC–MS analysis. Dried peptide samples were resuspended in 0.1% TFA and
analysed by nano-HPLC-ESI-MS/MS on a Q Exactive or an Orbitrap Elite
instrument (Thermo Fisher Scientiﬁc, Bremen, Germany) each connected to an
UltiMate 3000 RSLCnano HPLC system (Thermo Fisher Scientiﬁc, Dreieich,
Germany). The RSLC systems were equipped with PepMap C18 precolumns
(5mm 300 mm inner diameter; Thermo Scientiﬁc) for washing and
preconcentration of the peptides and C18 reversed-phase nano LC columns
(Acclaim PepMap RSLC columns; 50 cm 75mm inner diameter; particle size
2 mm, pore size 100Å; Thermo Scientiﬁc) for peptide separation at 40 C and a ﬂow
rate of 250 nlmin 1. Peptides from gradient-puriﬁed mitochondria of ATOM40-
RNAi cells, analysed on a Q Exactive, were separated using a binary solvent system
consisting of 4% dimethylsulphoxide (DMSO)/0.1% FA (solvent A) and 30%
ACN/48% methanol/4% DMSO/0.1% FA (solvent B). Peptides were eluted with a
gradient of 1–65% solvent B in 30min followed by 65–99% B in 5min and 5min at
99% B. The same solvent system was used for Orbitrap Elite MS analyses of whole
cells and organelle-enriched fractions obtained from ATOM40-RNAi experiments
as well as ERV1-RNAi samples. LC gradients were as follows: 1–65% B in 60min,
65–95% B in 5min, 5min at 95% B (ATOM40 RNAi, whole cells), 5–65% B in
50min, 65–95% B in 5min, 5min at 95% B (ATOM40 RNAi, organelle-enriched
fractions) or 1–65% B in 50min, 65–95% B in 5min, 5min at 95% B (ERV1 RNAi).
Separation of peptides derived from PEX14-RNAi cells, analysed on a Q Exactive,
was performed using 1.5% DMSO/0.1% FA (solvent A) and 86% ACN/1.5%
DMSO/0.1% FA (solvent B) with a gradient of 3–39% B in 30min, 39–95% B in
5min and 5min at 95% B. For Orbitrap Elite MS measurements of peptides from
SAM50-RNAi samples, analysed in two technical replicates, an LC gradient ranging
from 5–57% solvent B (B: 30% ACN/50% methanol/0.1% FA; A: 0.1% FA) in
265min followed by 57–99% B in 50min and 5min at 99% B was applied.
MS instruments, equipped with a Nanospray Flex ion source with
DirectJunction and stainless steel emitters (Thermo Scientiﬁc), were externally
calibrated using standard compounds. Orbitrap Elite parameters were as follows:
MS scans, m/z 370–1,700; resolution (R), 120,000 (at m/z 400); automatic gain
control (AGC), 1 106 ions; and max ﬁll time, 200ms. A TOP15 (ATOM40 RNAi,
organelle-enriched fraction) or TOP25 (ATOM40 RNAi, whole cells; SAM50- and
ERV1-RNAi samples) method was applied for low-energy collision-induced
dissociation of multiply charged peptides in the linear ion trap applying a
normalized collision energy of 35%, an activation q of 0.25, an activation time of
10ms, an AGC of 5 105, and a max ﬁll time of 150ms. The dynamic exclusion
time for previously selected precursor ions was set to 45 s. For the Q Exactive,
parameters were as follows: MS scan range, m/z 375–1,700; R, 70,000 (at m/z 200);
AGC, 3 106 ions; max ﬁll time, 60ms; TOP15-higher-energy collisional
dissociation of multiply charged peptides; AGC, 1 105; max ﬁll time (orbitrap),
120ms; normalized collision energy, 28%; dynamic exclusion time, 45 s.
MS data analysis. For protein identiﬁcation and quantiﬁcation, MS raw data were
processed using MaxQuant46 (version 1.5.2.8) and its integrated search engine
Andromeda47. Data derived from experiments of different RNAi target proteins
and cellular fractions were analysed separately. MS/MS data were searched against
all entries for T. brucei TREU927 listed in the respective fasta ﬁle downloaded from
the TriTryp database (version 8.1; 11,067), to which the 18 mitochondrially
encoded proteins (http://dna.kdna.ucla.edu/trypanosome/seqs/index.html) were
added. Database searches were performed with tryptic speciﬁcity (with a maximum
of two missed cleavages) not allowing cleavage N terminal to proline (Trypsin/P),
mass tolerances of 4.5 p.p.m. for precursor and 0.5Da for fragment ions,
carbamidomethylation of cysteine as ﬁxed and N-terminal acetylation and
oxidation of methionine as variable modiﬁcations. For data from SILAC-labelled
samples, Arg10 and Lys8 were set as heavy labels; for dimethyl-labelled samples,
dimethylLys0/dimethylNterLys0 and dimethylLys6/dimethylNterLys6 were set as
light and heavy labels, respectively. Protein identiﬁcation by MaxQuant/
Andromeda was based on at least one unique peptide with a minimum length of
seven amino acids and a false discovery rate of 0.01 applied to both peptide and
protein level. For stable isotope-based protein quantiﬁcation, only unique peptides
were considered and the minimum ratio count was set to one. The options
‘re-quantify’ and ‘match between runs’ were enabled.
In general, only proteins identiﬁed with at least two peptides (one of which
unique) and quantiﬁed in at least two biological replicates per experiment were
considered for further bioinformatics and statistical data analyses. For the
deﬁnition of the ATOM40-dependent mitochondrial importome based on the data
set obtained from gradient-puriﬁed mitochondria of ATOM40-RNAi cells, we also
included proteins identiﬁed with only one unique peptide across all replicates
if (i) the respective protein was detected and quantiﬁed in all four biological
replicates and (ii) identiﬁcation was based on MS/MS spectra (as opposed to
identiﬁcation by ‘match between runs’) in at least two independent replicates.
Annotated MS/MS spectra of single peptide identiﬁcations, generated using the
Viewer integrated in MaxQuant48 are shown in Supplementary Data 14. Lists of all
proteins identiﬁed and quantiﬁed in individual data sets are provided in
Supplementary Data 1, 3–5, 8 and 10. For all data sets, protein ratios (that is, RNAi
þ /Tet) of proteins fulﬁlling the ﬁlter criteria were log2-transformed and mean
log2 RNAi þ /Tet ratios determined across all replicates were plotted against the
P value calculated for each protein using a two-sided Student’s t-test.
Bioinformatics. Deﬁnition of mitochondrial and glycosomal importomes. To deﬁne
mitochondrial and glycosomal importomes, signiﬁcance thresholds for SILAC
ratios demarcating mitochondrial/glycosomal proteins from other proteins were
calculated. To this end, we ﬁrst deﬁned T. brucei-speciﬁc mitochondrial/glycosomal
and non-mitochondrial/non-glycosomal protein reference sets based on literature
and entries in the TriTrypDB49. The mitochondrial reference proteome consisted
of proteins annotated as mitochondrial in the TriTrypDB49 (version 8.1 as
of September 2014) completed by 18 mitochondrially encoded proteins
(http://dna.kdna.ucla.edu/trypanosome/seqs/index.html) and proteins reported as
mitochondrial in published studies7,50–61 covering, among others, mitochondrial
ribosomes59, the mitochondrial (outer) membrane proteome7,50, RNA-editing
proteins55, the mitochondrial RNA-binding complex 1 (MRB1) complex52,53,
mitochondrial carrier proteins60, the respiratome51 and the ATPase61. This
reference proteome was used to compare the data obtained in this study with the
set of so far known and published mitochondrial proteins. For the deﬁnition of
signiﬁcance thresholds, however, proteins of the OM (except for b-barrel proteins
and components of the ATOM complex) were removed from the list since a
number of OM proteins do not depend on ATOM40 for membrane insertion and,
thus, are not expected to be affected by the ATOM40 knockdown. Details about the
mitochondrial reference set comprising 1,238 proteins are provided in
Supplementary Data 2a. The non-mitochondrial reference proteome comprising
1,542 proteins included proteins used as such before to deﬁne the T. brucei
MitoCarta58 as well as proteins of the ﬂagellar proteome62 and cytosolic
ribosomal proteins63 less proteins with a predicted mitochondrial targeting
sequence as determined by TargetP 1.1 (http://www.cbs.dtu.dk/services/TargetP/)
(Supplementary Data 2b). The reference proteomes were used to calculate
F1 scores integrating the number of true positives (TP), false positives (FP) and
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false negatives (FN). The F1 score is deﬁned as harmonic mean of precision
[TP/(TPþ FP)] and sensitivity [TP/(TPþ FN)] and was calculated for given SILAC
ratios (mean log2 values) starting at the lowest ratio at which at least one TP and
one FP were present in the data pool and increasing stepwise in 0.01 increments
until the maximum ratio was reached. This calculation was performed for both the
mitochondrial and the non-mitochondrial reference proteome resulting in distinct
F1 scores for each reference proteome. At the ratio giving the maximum F1 score,
the number of proteins in the data pool that are present in the reference proteome
tested is highest and the number of proteins present in the opposite reference
proteome is lowest. The maximum F1 score that imposes the more stringent
ﬁlter on the data set was set as signiﬁcance threshold (that is, t2¼  0.62;
see Supplementary Fig. 4) to deﬁne the mitochondrial importome. Thus, proteins
with a SILAC ratio of less than or equal to  0.62 and a P value of o0.05 were
considered signiﬁcantly decreased in abundance in gradient-puriﬁed mitochondria
from ATOM40 knockdown compared to control cells and considered as
mitochondrial proteins of high conﬁdence.
The reference set for glycosomal proteins was based on a study of the
glycosomal proteome for the procyclic form of T. brucei and included all
glycosomal proteins classiﬁed therein as highly conﬁdent38 (Supplementary
Data 11a). For the non-glycosomal reference proteome, the set of mitochondrial
reference proteins as described above reduced by all entries annotated as
glycosomal proteins of high conﬁdence by Gu¨ther et al.38 was used (Supplementary
Data 11b). Signiﬁcance thresholds based on F1 scores were determined as described
above for the mitochondrial importome and were as follows: t2¼  0.59 for the
glycosomal and t1¼  0.33 for the non-glycosomal reference proteome. Proteins
exhibiting a SILAC ratio of less than or equal to  0.59 and a P value of o0.05
were classiﬁed as glycosomal proteins.
MIA pathway substrate prediction. Classical MIA pathway substrates present in
the genome of T. brucei were predicted based on a global Cx3C/Cx9C motif search
approach. We searched the genome of Trypanosoma brucei brucei TREU927 for
proteins (o50 kDa) containing two or more Cx3C or Cx9C motifs, which is
characteristic for mitochondrial IMS proteins, using the ‘Protein Motif Pattern’ tool
implemented in the TriTrypDB. In addition, a list of ‘MIA substrate-like’ proteins
with sequence or structural similarity to MIA substrates described in other
organisms was assembled. This list contains candidates from a domain-based
search (similar to Cavallaro64), which was performed using the ‘InterPro Domain’
tool of the TriTrypDB with the following search criteria: organism, Trypanosoma
brucei brucei TREU927; Pfam domains, PF06747, PF08583, PF05051, PF02297,
PF05676 and PF10203; Interpro domain, IPR009069. The list was extended by
published tiny TIM-like proteins31,33 and proteins referred to as homologues of
known MIA substrates in the TriTrypDB. For a complete list of the predicted MIA
pathway substrates, see Supplementary Data 9.
Statistical signiﬁcance test and GO analysis. For statistical signiﬁcance testing,
we used the two-sided Fisher’s exact test to calculate P values. Raw P values were
corrected using the Benjamini–Hochberg procedure, which controls the false
discovery rate at signiﬁcance level alpha. In the ERV1 knockdown experiment,
proteins with a P value o0.05 and a twofold decrease in abundance were
considered signiﬁcantly affected by the ERV1 knockdown. For conﬁrmation, this
set of proteins was tested for overrepresentation of predicted MIA substrate-like
proteins or Cx3C/Cx9C motif-containing proteins against all proteins quantiﬁed in
this experiment. Both classes of predicted MIA pathway substrates as well
as their combination were highly enriched indicated by P values of 6.05E 22
(MIA substrate-like), 6.56E 18 (Cx3C/Cx9C motif) and 1.29E 19 (combined).
GO enrichment analysis of proteins signiﬁcantly reduced on PEX14 knockdown
was based on GO terms provided by the TriTrypDB (version 8.1). For each
protein with GO annotation, missing information about ancestor terms were
retrieved using the GO.DB R package, lists of GO terms were reduced to
GO Slim terms according to the ‘GO slim Developed by GO Consortium’ database
(http://geneontology.org/), and redundant GO terms were removed. The analysis of
GO terms that are overrepresented among the glycosomal candidate proteins
was performed using the TopGO R package and all proteins quantiﬁed in the
PEX14-RNAi dataset (Supplementary Data 10) as background. GO terms with
a corrected P value of o0.05 were considered enriched.
Blast analysis. For the identiﬁcation of yeast (that is, Saccharomyces cerevisiae),
mouse and human proteins homologous to the new mitochondrial candidate
proteins detected in T. brucei in this study, a blastp65 search was performed. The
protein sequences of the T. brucei candidate proteins were searched against
a concatenated database containing the protein sequences present in the
Saccharomyces Genome Database (http://www.yeastgenome.org/) and in the
UniProt proteome sets for human and mouse (http://www.uniprot.org) as of May
2016 (containing a total of 158,824 entries). The threshold for the expectation value
was set to 0.001 and the 10 hits with the highest expectation values were retrieved.
In addition, a bitscore threshold of 50 was applied. GO slim terms were assigned to
all hits resulting from the blastp search. The results of the Blast analysis are
provided in Supplementary Data 7.
Further bioinformatics tools. For processing of MaxQuant result ﬁles (that is, the
‘proteinGroups.txt’ ﬁle), data visualization, and subsequent statistical and
bioinformatics data analyses, an in-house developed software based on R was used
including the following R packages: base, data.table, data sets, ﬂux, ggplot2, GO.db,
gplots, graphics, grDevices, grid, gtools, methods, pastecs, reshape2, silvermantest,
stats, stringr, topGO, utils, VennDiagram and Vennerable. Predictions of N
terminal mitochondrial targeting sequences were performed using TargetP 1.1
(http://www.cbs.dtu.dk/services/TargetP/) and MitoFates (http://mitf.cbrc.jp/
MitoFates/cgi-bin/top.cgi). PSORTII (https://psort.hgc.jp/) was used for cellular
localization prediction.
Statistical analysis. Number of replicates, controls and statistical tests are in
accordance with published studies employing comparable techniques and are
generally accepted standards in the ﬁeld. Statistical tests to determine sample size
were not employed. To determine proteins signiﬁcantly affected by RNAi-mediated
knockdown of the target protein, a two-sided Student’s t-test was performed.
Protein ratios represent fold change of RNAi-induced samples compared to
uninduced control samples. The data obtained were normally distributed, thereby
meeting the assumption of the statistical test. Quantitative MS experiments were
performed in at least three biological replicates.
Immunoﬂuorescence microscopy. Expression of C-terminally triple c-Myc-tag-
ged candidate proteins was induced for 1 day. Cells were ﬁxed with 4% paraf-
ormaldehyde in PBS and permeabilized with 0.2% Triton X100 in PBS. Cells were
post ﬁxed in cold methanol and slides mounted with VectaShield containing
40,6-diamidino-2-phenylindole (Vector Laboratories, Product No. H-1200). Images
were acquired with a DFC360 FX monochrome camera (Leica Microsystems)
mounted on a DMI6000B microscope (Leica Microsystems).
Northern blotting. Total RNA was isolated by acid guanidinium thiocyanate-
phenol-chloroform extraction54 from uninduced and induced (3 days) ATOM40-
RNAi cells. RNA was separated on a 1% (w/v) agarose gel in 20mM MOPS/KOH
buffer pH 7.0 containing 0.5% (v/v) formaldehyde. Northern probes were
generated by PCR from genomic DNA, gel-puriﬁed and radioactively labelled using
the Prime-a-Gene labelling system (Promega, Product No. U1100). A list of
oligonucleotide primers is provided (Supplementary Data 13). Full scans Northern
blots are shown in Supplementary Fig. 8.
Antibodies. Antibodies used in this study were: mouse anti-c-Myc (Invitrogen,
Product No. 132500, dilution 1:2,000 for immunoblotting, 1:50 for immuno-
ﬂuorescence), mouse anti-EF1a (Merck Millipore, Product No. 05-235, 1:10,000),
goat anti-mouse Alexa Fluor 633 conjugated (Invitrogen, Product No. A21052,
1:1,000) and goat anti-rabbit FITC conjugated (Sigma, Product No. F0382, 1:1,000);
polyclonal rabbit anti-ATOM40 (1:1,000 for both immunoblotting and immuno-
ﬂuorescence), anti-VDAC (1:1,000), anti-COXIV (1:1,000), anti-CYT C1 (1:1,000),
anti-TIM9 (1:20) and anti-CYT C (1:100) were previously produced in our
laboratory7,15,44. Mouse anti-REAP1 (1:1,500)66, rabbit anti-mtHSP70 (1:1,000)67,
rabbit anti-MCP5 (1:2,500)68, rabbit anti-LIPDH (1:5,000)69, rabbit anti-PEX14
(1:1,000)70, rabbit anti-aldolase (1:50,000)71, rabbit anti-GAPDH (1:50,000)72,
rabbit anti-G3PDH (1:1,000) and rabbit anti-GIM5 (1:10,000)37 were kindly
provided by L. Krauth-Siegel, S.H. Hajduk, R. Jensen, F. Voncken, P. Michels,
A. Jardim and C. Clayton, respectively. Full scans for western blots are shown in
Supplementary Fig. 8.
Miscellaneous. For the generation of whole-cell extracts, cells were washed with
PBS and directly lysed in SDS–PAGE loading buffer. SDS-PAGE and Western
blotting of proteins to polyvinylidene diﬂuoride membranes were performed
according to standard protocols.
Data availability. The MS proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE73 partner repository with the data
set identiﬁers PXD004917 (data set: ATOM40 RNAi, gradient-puriﬁed
mitochondria), PXD005725 (ATOM40 RNAi, whole-cell lysates), PXD004950
(ATOM40 RNAi, organelle-enriched fraction), PXD004979 (SAM50 RNAi),
PXD005730 (ERV1 RNAi) and PXD004972 (PEX14 RNAi). The remaining data
are available within the article and its Supplementary Information ﬁles and from
the corresponding authors on reasonable request.
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